Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-22T16:23:11.992Z Has data issue: false hasContentIssue false

The Relationship between Parkinson's Disease and Dementia: A study using Proton NMR Imaging Parameters

Published online by Cambridge University Press:  29 January 2018

J. A. O. Besson*
Affiliation:
Department of Mental Health, University of Aberdeen, Clinical Research Centre, Royal Cornhill Hospital, Aberdeen AB9 2ZH
W. J. Mutch
Affiliation:
Aberdeen Royal Infirmary
F. W. Smith
Affiliation:
Aberdeen Royal Infirmary
F. M. Corrigan
Affiliation:
Department of Mental Health, University of Aberdeen
*
Correspondence

Abstract

The value of the spin lattice relaxation time (T1) obtained during nuclear magnetic resonance imaging of the brain was studied in patients with idiopathic Parkinson's disease, with and without dementia. T1 increases significantly in the basal ganglia and cerebral white matter of the demented and non-demented groups. T1 of the cerebral white matter correlates with the severity of dementia.

Type
Papers
Copyright
Copyright © 1985 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Besson, J. A. O., Corrigan, F. M., Foreman, E. I., Eastwood, L. M., Smith, F. W. & Ashcroft, G. W. (1985) NMR imaging in dementia. British Journal of Psychiatry, 146, 3135.Google Scholar
Bydder, G. M., Steiner, R. E., Young, I. R., Hall, A. S., Thomas, D. J., Marshall, J., Pallis, C. A. & Legg, N. J. (1982) Clinical NMR imaging of the brain—140 cases. American Journal of Roentgenology, 130, 215236.Google Scholar
Celesia, G. G. & Wanamaker, W. M. (1972) Psychiatric disturbances in Parkinson's disease. Diseases of the Nervous System, 33, 577583.Google Scholar
Eastwood, L. M., Hutchison, J. M. S. & Besson, J. A. O. (1985) Nuclear magnetic resonance (NMR); imaging biochemical change. British Journal of Psychiatry, 146, 2631.CrossRefGoogle ScholarPubMed
Greenfield, J. G. (1963) In Greenfield's Neuropathology, 2nd Edition. (Eds. Blackwood, W., McMenemey, W. H., Meyer, A., Norman, R. M. and Russell, D. S.). London: Edward Arnold.Google Scholar
Hoehn, M. M. & Yahr, M. D. (1967) Parkinsonism—onset, progression and mortality. Neurology, 17, 427442.CrossRefGoogle ScholarPubMed
Marsden, C. D. (1982) Basal ganglia disease. Lancet, 11, 11411147.Google Scholar
Mindham, R. H. S. (1970) Psychiatric symptoms in Parkinsonism. Journal of Neurology, Neurosurgery and Psychiatry, 33, 188191.Google Scholar
Perry, R. H., Tomlinson, B. E., Candy, J. M., Blessed, G., Foster, J. F., Bloxham, C. A. & Perry, E. R. (1983) Cortical cholinergic deficit in mentally impaired Parkinsonian patients. Lancet, 11, 789790.Google Scholar
Pollock, M. & Hornabrook, R. W. (1966) Prevalence, natural history and dementia of Parkinson's disease. Brain, 89, 429448.Google Scholar
Webster, D. D. (1968) Critical anslysis of the disability in Parkinson's disease. Modern Treatment, 5, 257282.Google Scholar
Young, I. R., Hall, A. S., Pallis, C. A., Bydder, G. M., Legg, N. J. & Steiner, R. E. (1981) Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet, 11, 10631066.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.